Prazepam is a DEA Schedule IV controlled substance. Substances in the DEA Schedule IV have a low potential for abuse relative to substances in Schedule III. It is a Depressants substance. It is grouped under the following drug class(es): Anxiolytics, Benzodiazepines and Schedule IV controlled substances. Its therapeutic use is listed as antianxiety drugs. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Centrax, Demetrin and Trepidan. It is listed as a controlled drug substance (Schedule IV). Its PubChem CID is 4890.
Prazepam
| CAS No | 2955-38-6 |
|---|---|
| Molecular Formula | C19H17ClN2O |
| Molecular Weight | 324.8 g/mol |
| Synonyms | 7-chloro-1-(cyclopropylmethyl)-5-phenyl-3H-1,4-benzodiazepin-2-one |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Prazepam is a DEA Schedule IV controlled substance. Substances in the DEA Schedule IV have a low potential for abuse relative to substances in Schedule III. It is a Depressants substance.
The listed CAS number is 2955-38-6.
The listed molecular formula is C19H17ClN2O.
The listed molecular weight is 324.8 g/mol.
7-chloro-1-(cyclopropylmethyl)-5-phenyl-3H-1,4-benzodiazepin-2-one.
The source lists Centrax, Demetrin and Trepidan.